EXEL: Exelixis Inc
EXEL exchange rate has changed by 0.40% for today. During the day, the instrument was traded at a low of 52.22 and at a high of 52.98.
Follow Exelixis Inc dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
EXEL News
- No. 1 Rated Drugmaker Lilly Hits Record High, Leads 18 Onto Best Growth Stock Lists
- Exelixis (EXEL) Up 6% Since Last Earnings Report: Can It Continue?
- Why Exelixis (EXEL) is a Top Growth Stock for the Long-Term
- Why Exelixis (EXEL) is a Top Value Stock for the Long-Term
- Why Exelixis (EXEL) is a Top Momentum Stock for the Long-Term
- Dow Jones Futures: Stock Market Hits Highs On U.S.-Iran Deal; Dell Surges On Earnings
- Exelixis, Inc. (EXEL) Presents at Bernstein 42nd Annual Strategic Decisions Conference Transcript
- Exelixis: Financial Performance Improves Faster Than Market Expectations (NASDAQ:EXEL)
- Tracking Renaissance Technologies (RenTec) 13F Portfolio – Q1 2026 Update
- Exelixis, Inc. (EXEL) Presents at Stifel 2026 Targeted Oncology Virtual Forum Transcript
- EXEL Collaborates With MRK for Late-Stage Colorectal Cancer Study
- Exelixis, Inc. (EXEL) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript
- Exelixis (EXEL) is a Top-Ranked Momentum Stock: Should You Buy?
- Stock Market Soars On Tumbling Oil Prices, Strong Earnings: Weekly Review
- EXEL Q1 Earnings Top Estimates, Colorectal Cancer Drug in Focus
- Here's Why Exelixis (EXEL) is a Strong Value Stock
- Exelixis, Inc. (EXEL) Q1 2026 Earnings Call Transcript
- Exelixis (EXEL) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
- Exelixis (EXEL) Tops Q1 Earnings Estimates
- Here's Why Exelixis (EXEL) is a Strong Growth Stock
- Exelixis (EXEL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
- Recursion Pharmaceuticals May Be Losing Ground To Its Peers (NASDAQ:RXRX)
- AI Chip Gear Maker Lam Research Leads 13 Stocks Onto These Top IBD Screens
- Why Exelixis (EXEL) is a Top Value Stock for the Long-Term
Frequently Asked Questions
What is EXEL stock price today?
Exelixis Inc stock is priced at 52.70 today. It trades within 52.22 - 52.98, yesterday's close was 52.49, and trading volume reached 4364. The live price chart of EXEL shows these updates.
Does Exelixis Inc stock pay dividends?
Exelixis Inc is currently valued at 52.70. Dividend policy depends on the company, while investors also watch 34.99% and USD. View the chart live to track EXEL movements.
How to buy EXEL stock?
You can buy Exelixis Inc shares at the current price of 52.70. Orders are usually placed near 52.70 or 53.00, while 4364 and 0.55% show market activity. Follow EXEL updates on the live chart today.
How to invest into EXEL stock?
Investing in Exelixis Inc involves considering the yearly range 36.00 - 52.98 and current price 52.70. Many compare 4.25% and 21.09% before placing orders at 52.70 or 53.00. Explore the EXEL price chart live with daily changes.
What are Exelixis Inc stock highest prices?
The highest price of Exelixis Inc in the past year was 52.98. Within 36.00 - 52.98, the stock fluctuated notably, and comparing with 52.49 helps spot resistance levels. Track Exelixis Inc performance using the live chart.
What are Exelixis Inc stock lowest prices?
The lowest price of Exelixis Inc (EXEL) over the year was 36.00. Comparing it with the current 52.70 and 36.00 - 52.98 shows potential long-term entry points. Watch EXEL moves on the chart live for more details.
When did EXEL stock split?
Exelixis Inc has gone through stock splits historically. These changes are visible in , 52.49, and 34.99% after corporate actions.
- Previous Close
- 52.49
- Open
- 52.41
- Bid
- 52.70
- Ask
- 53.00
- Low
- 52.22
- High
- 52.98
- Volume
- 4.364 K
- Daily Change
- 0.40%
- Month Change
- 4.25%
- 6 Months Change
- 21.09%
- Year Change
- 34.99%
- Act
- Fcst
- Prev